Aarti Surfactants Ltd (AARTISURF)

📊 Quarterly Results (₹ Cr)

The company has demonstrated a clear upward trajectory in financial performance, with revenue growing from ₹179 lakhs in September 2025 to ₹273 lakhs in June 2026, and net profit increasing from ₹2 lakhs to ₹9.08 lakhs over the same period. Operating margins have improved from 2.8% to 5.7%, and net profit margins have expanded alongside rising EPS from ₹1.84 to ₹10.63, indicating operational efficiency gains. Despite a significant increase in capital expenditures of ₹4,510.51 crore, the business has generated strong financing cash flows, supporting overall liquidity. The debt-equity ratio has stabilized around 0.48–0.49, reflecting prudent leverage management amid growth investments.

🔮 Management Outlook & What's Next

Management has expressed confidence in sustained growth through operational improvements and strategic leadership strengthening, as reflected in board-level changes and reappointments effective August 20, 2027. While no explicit long-term financial targets were provided in the latest filings, the consistent focus on margin improvement, capital allocation discipline, and shareholder returns — including a recommended 10% dividend — suggests a shareholder-friendly stance. Management has not provided forward guidance on revenue or margins, but the reappointment of key executives and board restructuring indicates a focus on governance and strategic continuity ahead of the upcoming AGM.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

The balance sheet shows a stable and healthy financial position, with equity remaining flat at ₹8 lakhs while reserves grew from ₹224 lakhs to ₹236 lakhs over the latest two years, indicating retained earnings. Borrowings have modestly increased from ₹109 crore to ₹118 crore, but remain well within manageable levels relative to equity and assets. Total assets have grown from ₹477 crore to ₹517 crore, reflecting investments in operations, likely tied to capital expenditures of ₹4,510.51 crore. The company maintains a strong current ratio of 1.35 and a conservative debt-equity ratio of 0.48, suggesting disciplined capital management and low financial risk despite high capex.

💰 Cash Flow Statement (₹ Cr)

👥 Shareholding Pattern

Promoter holding has remained stable around 49.84–49.92% over the past year, indicating no aggressive dilution or stake sales. Institutional interest is emerging, with FII holdings rising from 0% to 0.14% and DII from 0.3% to 0.8% over the last four quarters, suggesting growing institutional confidence. The number of shareholders has slightly declined from 37,015 to 35,149, which may reflect consolidation but not significant exits. There are no signs of promoter pledging or major shareholder activism, and the shareholder base remains broad-based with a large public float.

⚖️ Peer Comparison — Chemicals

🔗 Peer Stock Analyses

⚠️ Risk Factors

1. High capital expenditure levels of over ₹4,500 crore may pressure near-term cash flows, despite strong financing activity, raising concerns about sustainability if growth does not materialize. 2. Operating margins remain relatively low at 5.7%, leaving limited room for error if input costs rise or pricing pressures emerge in the competitive surfactants market. 3. The company’s profitability is still emerging, with net profit margins expanding from 1% to 3.3% over two years, making it vulnerable to execution risks in scaling operations. 4. Potential dilution from the 9,000 ESOP options granted at a low exercise price could increase share supply if exercised, impacting per-share metrics.

📋 Recent Filings

• Announcement2026-09-25Aarti Surfactants Ltd announced the closure of its insider trading window effective October 1, 2026, until 48 hours after Q2 FY2026 results are declar…
• 🟡 buyback redemption2026-09-25Aarti Surfactants received a customs order on September 24, 2026, reclassifying imported goods, confiscating 171.444 MTs of goods valued at Rs. 2.30 c…
• 🟡 Board Meeting2026-09-12Aarti Surfactants announced the resignation of Non-Executive Independent Director Nisha B. Shah effective September 11, 2026, citing insufficient time…
• 🔴 Corporate Action2026-09-04Aarti Surfactants announced a record date of September 22, 2026, for a final dividend of Re. 1 per share (10% yield) on FY 2025-26, payable after AGM …
• 🟡 Board Meeting2026-09-04Aarti Surfactants Limited announced its 8th Annual General Meeting scheduled for September 29, 2026, via video conferencing, along with the distributi…
• 🔴 annual report2026-09-04Aarti Surfactants held its 8th AGM on September 29, 2026, virtually, releasing the FY 2025-26 annual report. The company reported revenue of **₹85,912…
• 🔴 Announcement2026-09-03Aarti Surfactants Ltd announced its credit rating agency transition from CARE Ratings to CRISIL Ratings, with CRISIL upgrading its long-term bank loan…
• 🔴 Corporate Action2026-08-31Aarti Surfactants announced incorporation of its wholly owned subsidiary Precision Ingredients USA Inc in Wyoming on August 27, 2026, to market and tr…
• 🟡 Board Meeting2026-08-24Aarti Surfactants approved the grant of 9,000 stock options under its 2024 ESOP plan to eligible employees at a Rs.10 exercise price per option, vesti…
• 🟡 Board Meeting2026-08-22Aarti Surfactants announced board approval of key leadership changes effective August 20, 2027: reappointing Nikhil Desai as CEO & MD for 5 years, rea…

🧠 Analyst's Read

Aarti Surfactants is transitioning from a small-cap to a more established mid-tier chemical player, underpinned by consistent financial improvement, leadership continuity, and disciplined capital management. The key watchpoints are whether margin expansion can be sustained amid cyclical demand and input cost volatility, and how effectively the new leadership structure supports strategic execution. Investors should monitor the AGM outcome for leadership approvals and any updates on growth capex allocation.

Based on filing content and financial data. Not a recommendation.